Prevalence of various urination disorders in residents of the Republic of Dagestan
- Authors: Kazilov Y.B1,2, Gadzhieva Z.K3, Mugutdinov T.M4, Kazilov B.R4
-
Affiliations:
- SRI of Uronephrology and Human Reproductive Health
- SBI RD «Republican Urological Centre»
- SBEI HPE «First Moscow State Medical University n.a. I.M. Sechenov» of RMH
- FSBEI HPE «Dagestan State Medical University» of RMH
- Issue: No 4 (2016)
- Pages: 42-47
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/286456
- ID: 286456
Cite item
Abstract
Purpose: to evaluate the prevalence of various urination disorders in residents of the Republic of Dagestan, and, thus, to improve their diagnosis and treatment. Materials and methods. 584 residents (264 men and 320 women) from different regions of the Republic of Dagestan took part in an anonymous questionnaire survey: 165 residents of Makhachkala, including 92 men and 73 women; 86 residents of Derbent and villages of Southern Dagestan, including 30 men and 56 women; 73 residents of Khasavyurt and Kizilyurt, including 34 men and 39 women; 53 residents of Buynaksk, including 19 men and 34 women; 42 residents of Izberbash, including 19 men and 23 women; 58 residents of the Kaspiysk, 29 men and 29 women; 42 residents of Kayakent, 4 men and 38 women; 65 residents of other regions of the Republic of Dagestan (Karabudakhkent, Gumbet, Gunibsk, Shamil, Khunzakh, Botlikh, Kazbek, Levashin, Tlyaratin, and Tsumadin regions), 37 men and 28 women. Results. According to the survey of the residents of the Republic of Dagestan, a significant prevalence of various urinary disorders (63.5%) was found among both men (61.7%) and women (65.0%). Unfortunately, not all patients seek medical advice with complaints of dysuria (55.5%). The fact that 18.8% of patients do not know that they can get help, and 24.1% believe that they do not have a good doctor in their region can be considered as the most an unfavorable moment in terms of the reasons for the refusal of visiting a doctor.. Conclusions. All this findings suggest the need for educational programs both for physicians and the population (educative activities).
Full Text
About the authors
Yu. B Kazilov
SRI of Uronephrology and Human Reproductive Health; SBI RD «Republican Urological Centre»
Email: dugurolog@mail.ru
Z. K Gadzhieva
SBEI HPE «First Moscow State Medical University n.a. I.M. Sechenov» of RMH
Email: zgadzhieva@ooorou.ru
T. M Mugutdinov
FSBEI HPE «Dagestan State Medical University» of RMH
B. R Kazilov
FSBEI HPE «Dagestan State Medical University» of RMH
References
- Kupelian V., Wei J.T., O’Leary M.P., Kusek J.W., Litman H.J.,Link C.L., McKinlay J.B.; BACH Survery Investigators. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) survey. Arch Intern Med. 2006;166: 2381-2387.
- Taylor B.C., Wilt T.J., Fink H.A., Lambert L.C., Marshall L.M., Hoffman A.R., Beer T.M., Bauer D.C., Zmuda J.M., Orwoll E.S. Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalence, severity and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006; 68: 804-809.
- Wei J.T., Calhoun E., Jacobsen S.J. Urologic diseases in America project: benign prostatic hyperplasia. J. Urol. 2005;173:1256-1261.
- Boyle P., Robertson C., Mazzetta C., Keech M., Hobbs F.D., Fourcade R., Kiemeney L., Lee C.; UrEpik Study Group. The prevalence of lower urinary tract symptoms in men and women in four centres: the UrEpik study. BJU Int. 2003;92:409-414.
- Trueman P., Hood S.C., Nayak U.S. et al. Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int. 1999;83:410-415.
- Sexton C.C., Coyne K.S., Kopp Z.S., Irwin D.E., Milsom I., Aiyer L.P., Tubaro A., Chapple C.R., Wein A.J. EpiLUTS Team. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int. 2009;103 (Suppl. 3):12-23.
- Мазо Е.Б., Кривобородов Г.Г. Медикаментозное лечение гиперактивного мочевого пузыря. Регулярные выпуски «РМЖ» №8 от 27.04.2004. с. 522
- Abrams P., Wein A.J. Introduction: Overactive bladder and its treatmens. Urology. 2000;55(Suppl. 5A): 1-2.
- Abrams P., Artibani W., Gajewski J.B., Hussain I. Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures. Urology. 2006; 68(2 Suppl.):17-28.
- Гаджиева З.К. Функциональное состояние и медикаментозная коррекция нарушений мочеиспускания у женщин в климактерии. Автореф. дисс. канд. мед. наук. М., 2001. 189 с.
- Корнеев И.А., Алексеева Т.А., Коган М.И., Пушкарь Д.Ю. Эпидемиология расстройств мочеиспускания у мужчин Российской Федерации. Урология. 2016;2(приложение 2):70-75